These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7836915)

  • 1. Human immunoglobulin (IgG) induced deletion of IgM rheumatoid factor B cells in transgenic mice.
    Tighe H; Heaphy P; Baird S; Weigle WO; Carson DA
    J Exp Med; 1995 Feb; 181(2):599-606. PubMed ID: 7836915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for membrane IgD in the tolerance of pathological human rheumatoid factor B cells.
    Soulas P; Koenig-Marrony S; Julien S; Knapp AM; Garaud JC; Pasquali JL; Martin T
    Eur J Immunol; 2002 Sep; 32(9):2623-34. PubMed ID: 12207347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG.
    Tighe H; Warnatz K; Brinson D; Corr M; Weigle WO; Baird SM; Carson DA
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):646-51. PubMed ID: 9012838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen.
    Brink R; Goodnow CC; Crosbie J; Adams E; Eris J; Mason DY; Hartley SB; Basten A
    J Exp Med; 1992 Oct; 176(4):991-1005. PubMed ID: 1402669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and proliferation signals in mouse B cells. V.A. comparison of the effects of intact (IgG) and F (ab')2 anti-mu or anti-delta antibodies.
    Klaus GG; Bijsterbosch MK; Parkhouse RM
    Immunology; 1985 Apr; 54(4):677-83. PubMed ID: 2984110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen.
    Kyburz D; Corr M; Brinson DC; Von Damm A; Tighe H; Carson DA
    J Immunol; 1999 Sep; 163(6):3116-22. PubMed ID: 10477577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice.
    Tighe H; Chen PP; Tucker R; Kipps TJ; Roudier J; Jirik FR; Carson DA
    J Exp Med; 1993 Jan; 177(1):109-18. PubMed ID: 8418195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive selection of IgG
    Sundling C; Lau AWY; Bourne K; Young C; Laurianto C; Hermes JR; Menzies RJ; Butt D; Kräutler NJ; Zahra D; Suan D; Brink R
    Immunity; 2021 May; 54(5):988-1001.e5. PubMed ID: 33857421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells.
    Shlomchik MJ; Nemazee DA; Sato VL; Van Snick J; Carson DA; Weigert MG
    J Exp Med; 1986 Aug; 164(2):407-27. PubMed ID: 3088205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
    Yamashita T; Koyama J
    J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteroclitic polyclonal and monoclonal anti-Gm(a) and anti-Gm(g) human rheumatoid factors react with epitopes induced in Gm(a-), Gm(g-) IgG by interaction with antigen or by nonspecific aggregation. A possible mechanism for the in vivo generation of rheumatoid factors.
    Williams RC; Malone CC; Casali P
    J Immunol; 1992 Sep; 149(5):1817-24. PubMed ID: 1380541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice.
    Theofilopoulos AN; Balderas RS; Hang L; Dixon FJ
    J Exp Med; 1983 Sep; 158(3):901-19. PubMed ID: 6224885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial IgG rheumatoid factors show evidence of an antigen-driven immune response and a shift in the V gene repertoire compared to IgM rheumatoid factors.
    Randen I; Pascual V; Victor K; Thompson KM; Førre O; Capra JD; Natvig JB
    Eur J Immunol; 1993 Jun; 23(6):1220-5. PubMed ID: 8500520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of in vitro monoclonal human rheumatoid factor synthesis by antiidiotypic antibody. Target cells and molecular requirements.
    Koopman WJ; Schrohenloher RE; Barton JC; Greenleaf EC
    J Clin Invest; 1983 Oct; 72(4):1410-9. PubMed ID: 6605366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro IgG rheumatoid factor production by CD5-negative murine B cells in response to immune complexes of lipopolysaccharide.
    Taguchi H; Kanoh M; Takubo N; Kadota S; Kanazawa K; Shibata T; Utsumi S
    Clin Exp Immunol; 1990 Oct; 82(1):128-32. PubMed ID: 1698578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients.
    Karpatkin S; Nardi MA; Hymes KB
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2263-7. PubMed ID: 7892259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance.
    Ota T; Aoki-Ota M; Tsunoda K; Nishikawa T; Koyasu S; Amagai M
    Int Immunol; 2008 Oct; 20(10):1351-60. PubMed ID: 18765425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
    Doekes G; Schouten J; Cats A; Daha MR
    Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.